Fingerprint
Dive into the research topics of 'Cardiovascular outcomes with ertugliflozin in type 2 diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cardiovascular outcomes with ertugliflozin in type 2 diabetes
for the VERTIS CV Investigators
Research output: Contribution to journal › Article › peer-review
894
Scopus
citations